Bob's Discount Furniture Inc (BOBS)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-16
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-16
Research Workspace
Put BOBS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisThis stock is volatile — it swings about 2% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskBOBS depends on steady revenue growth, yet its latest revenue growth has no broader trajectory history. Q2 FY2026 revenue grew 8.8% year over year, while earnings were inline. A clean valuation multiple is unavailable, so the valuation comparison is low-confidence. The price is roughly in line with the growth we forecast, despite the weak sector backdrop. Our model puts the next-quarter miss probability near 25%. Peer multiples imply a price about 23% below where it trades. Our read remains intact; this read is provisional.
Trailing returns as of 2026-10-16. BOBS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 13 analysts currently covering BOBS (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for BOBS in the last 4 months.
Continue this research
Compare BOBS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BOBS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-10-16. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Other Specialty Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put BOBS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Reaffirm full fiscal year 2026 guidance
Q2 revenue growth supports full fiscal year guidance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-16. EPS is implied from price ÷ P/E. Not investment advice.
Current $14.87
The last 12 months of price, then the range of analyst 12-month targets from today’s $14.87.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Advances: Reaffirm full fiscal year 2026 guidance
Expansion supports growth objectives for fiscal year 2026.
Improving financials support full fiscal year guidance.
Threatens: Reaffirm full fiscal year 2026 guidance
Downgrade indicates potential challenges to growth.